World Alzheimer's Day 2021: The Power of Knowledge

World Alzheimer's Day is an international campaign organised by Alzheimer's Disease International to raise awareness and highlight issues faced by people affected by dementia. It takes place every year on September 21st and is the focus of World Alzheimer's Month.

Dementia is one of the biggest challenges we face, with nearly 50 million people living with dementia worldwide. Yet 2 out of every 3 people globally believe there is little or no understanding of dementia in their countries.The impact of World Alzheimer's Month is growing, but the stigmatisation and misinformation that surrounds dementia remains a global problem. To tackle this challenge, we need to collaborate and share best practice with one another.

In support of this year’s theme – ‘Know dementia, know Alzheimer's’ - Elsevier presents a curated, open access collection of over 70 journal articles and book chapters focused on shining a light on the warning signs of dementia and the importance of a timely diagnosis.

Elsevier,

Neurobiology of Stress, Volume 8, February 2018

Varying biochemical responses to stress between sexes is what may result in sex being a risk factor for Alzheimer's disease (AD).
Elsevier,

Neurobiology of Stress, Volume 8, February 2018

Exposure to stress in early life has a correlation to the onset and progression of Alzheimer's disease -related neuropathology and cognitive decline.
Elsevier,

Neurobiology of Stress, Volume 8, February 2018

The article discusses how physical activity may be able to counterbalance the effects of stress on the development and progression of Alzheimer's disease (AD).
Elsevier,

Neurobiology of Sleep and Circadian Rhythms, Volume 2, 2017

4,5,6,7-tetrahydroisoxazolo-[5,4-c]pyridine-3-ol (THIP) can be used to enhance sleep in two Drosophila models of Alzheimer's disease. Sleep can be used as a therapeutic to reverse Alzheimer's disease related deficits.
Elsevier,

Neurobiology of Sleep and Circadian Rhythms, Volume 2, 2017

Amyloid β (Aβ) is believed to play a significant role in the development of sleep disturbances in the preclinical and clinical phases of Alzheimer's disease (AD).
Elsevier,

Japan and the World Economy, Volume 21, December 2009

Taking advantage of rich and original survey data and using a three-part model, this study examined whether the increase in care expenditure is the result of supplier-induced demand in the wake of the rise in the number of care providers following deregulation. We provide at most weak evidence that supplier density in the at-home care market is positively correlated with probability to use care or care expenditure.
Elsevier,

Heliyon, Volume 7, June 2021

This paper presents an appraisal of the literature, reports, and studies that seek to the possible role of Toxoplasma gondii in the development of Alzheimer's Disease.
Elsevier,

Heliyon, Volume 7, February 2021

Hippocampus segmentation on magnetic resonance imaging is of key importance for the diagnosis, treatment decision and investigation of neuropsychiatric disorders. In this paper we present a state-of-the-art, open source, ready-to-use, deep learning based hippocampus segmentation method.
Elsevier,

Heliyon, Volume 6, December 2020

Alzheimer poses lots of challenges in Low and Middle Income Countries, especially in Nigeria. This research found that gender disparities primarily affected the mental health intervention care pathways. The availability of mental health resources to support adult mental health were key factors which could influence mental health status.

Pages